Table 2.
Groups | Events/total (%) | HR (95% CI) | p Value | Adjusted HR (95% CI) | p-Value |
---|---|---|---|---|---|
SBP <110 mmHg | 66/368 (17.9) | ||||
Per 10-mmHg PP increase | 66/368 (17.9) | 0.85 (0.62–1.15) | .283 | / | / |
PP <37 mmHg | 36/177 (20.3) | Reference | .230 | Reference | / |
PP ≥37 mmHg | 30/191 (15.7) | 0.74 (0.46–1.20) | / | ||
110 ≤ SBP ≤140 mmHg | 136/862 (15.8) | ||||
Per 10-mmHg PP increase | 136/862 (15.8) | 1.18 (1.02–1.38) | .027 | 1.20 (1.03–1.40) | .019 |
PP <49 mmHg | 51/412 (12.4) | Reference | .013 | Reference | .018 |
PP ≥49 mmHg | 85/450 (18.9) | 1.56 (1.10–2.21) | 1.54 (1.08–2.20) | ||
SBP >140 mmHg | 57/351 (16.2) | ||||
Per 10-mmHg PP increase | 57/351 (16.2) | 1.22 (0.99–1.56) | .068 | 1.34 (0.97–1.76) | .097 |
PP <67 mmHg | 20/172 (11.6) | Reference | .026 | Reference | .014 |
PP ≥67 mmHg | 37/179 (20.7) | 1.84 (1.07–3.32) | 2.00 (1.15–3.48) |
Multivariable Cox proportional hazards regression model was adjusted for age, sex, reason for admission, NYHA class, smoking status, diabetes, dyslipidemia, eGFR, LDL-C, log10 Hs-cTNT, log10 NT-proBNP, LVEDD, LVESD, LVEF, LA diameter, E/e′, intravenous diuretics, intravenous inotropic agents.